1453 articles
P-SPAC (Unknown) SPCX (Unknown)

Florida Governor Ron DeSantis announced a $600 million expansion of Blue Origin's Cape Canaveral campus, adding an 830,000-square-foot manufacturing facility. The project will create 500 aerospace jobs averaging over $98,000 in salary and represents Blue Origin's largest commitment to Florida as rival SpaceX prepares to go public.

Show details
MGYOY (Energy)

Hungary's MOL received a two-week U.S. extension until June 6 to finalize negotiations to purchase a 56.16% stake in Serbia's NIS oil company from Russia's Gazprom Neft. The deal faces scrutiny because NIS is under U.S. sanctions imposed in October due to its Russian ownership, following Moscow's invasion of Ukraine. The transaction requires approval from both U.S. authorities and the Serbian government, which holds a 29.9% stake in NIS.

Show details
META (Communication Services) RDDT (Communication Services)

Reddit shares dropped 6% after Meta launched Forum, a standalone iOS app for online discussion groups that could compete directly with Reddit's core business. The move raises concerns about gradual erosion of Reddit's casual user base, particularly those with less community loyalty who simply seek answers online.

Show details
GILD (Healthcare)

The FDA approved Gilead Sciences' drug Hepcludex to treat chronic hepatitis delta virus (HDV), a rare and deadly liver infection that previously had no approved treatment options. HDV only affects people already infected with hepatitis B and can lead to liver scarring, cancer, organ failure, and death.

Show details
JD (Consumer Cyclical)

Chinese e-commerce giant JD.com is reportedly considering a £2 billion acquisition bid for The Very Group, a British online shopping platform, according to Sky News. The report has not been independently verified by Reuters. This potential deal would represent a significant cross-border acquisition in the e-commerce sector.

Show details
P-SPAC (Unknown) SPCX (Unknown)

SpaceX is implementing a phased lock-up release structure for its upcoming IPO, breaking from the standard 180-day restriction by allowing early share sales tied to quarterly earnings and performance milestones. The approach aims to prevent a massive wave of selling at once while stabilizing trading for the company targeting a $1.75 trillion valuation. This staggered system, more common during the 2020-2021 IPO boom, spreads potential volatility over six months rather than creating a single sell-off event.

Show details

U.S. gasoline prices have reached $4.55 per gallon, near four-year highs, as Memorial Day weekend begins, driven by a conflict between the U.S., Israel, and Iran that started February 28. Iran's blockade of the Strait of Hormuz has caused crude oil prices to spike more than 40% from pre-war levels, triggering what the article describes as a historic supply disruption.

Show details
NVO (Healthcare)

The European Medicines Agency recommended approval for Novo Nordisk's oral Wegovy weight-loss pill on May 22, positioning it to become the first oral weight-loss drug in Europe. This development gives Novo an edge over U.S. rival Eli Lilly in the intensifying competition for the European weight-loss drug market.

Show details
P-ANTH (Unknown) P-OPEA (Unknown) P-SPAC (Unknown) SPCX (Unknown)

SpaceX, OpenAI, and Anthropic plan to go public by end of 2026, but analysts warn these mega-IPOs from unprofitable companies could signal a market peak similar to the late-1990s dot-com bubble. SpaceX is targeting a $1.75 trillion valuation despite recording a $4.28 billion net loss in its latest quarter, while OpenAI has also yet to turn a profit.

Show details

The United Nations is releasing approximately $60 million from its emergency fund and deploying additional staff to contain an Ebola outbreak in the Democratic Republic of Congo's Ituri province. The outbreak, caused by the Bundibugyo strain for which no vaccine exists, has resulted in 160 suspected deaths out of 670 suspected cases and reportedly circulated undetected for about two months before identification last week.

Show details
HYMLF (Unknown)

Hyundai Motor is recalling 421,078 vehicles in the United States due to a software error that may cause brakes to apply unexpectedly. The recall was announced by the U.S. National Highway Traffic Safety Administration (NHTSA) on Friday, May 22. The issue poses a potential safety risk to drivers of affected Hyundai vehicles.

Show details
GBL (Unknown)

Private equity firm CVC Capital Partners and Belgian investment group GBL launched a €10.7 billion ($12.43 billion) voluntary cash takeover bid for Italian pharmaceutical company Recordati. The offer, made through a new Italian joint stock company, aims to delist Recordati from the stock exchange.

Show details
LNVGF (Technology) LNVGY (Technology)

Lenovo Group reported a 27% jump in Q4 revenue to $21.6 billion, significantly beating analyst expectations of $18.7 billion, driven by strong PC demand ahead of anticipated price hikes. The company's shares surged 15% following the announcement. Lenovo's performance comes amid a global memory chip shortage and rising prices, which the company managed through a diversified supplier base including Chinese producers.

Show details
P-FANA (Unknown)
Fanatics Dominates the Sports Collectibles Market
CNBC | Thu, 21 May 2026 19:56:29 -0400

Fanatics has secured exclusive FIFA World Cup collectibles licensing rights starting in 2031, displacing Panini and expanding its dominance across a $100 billion sports collectibles market. The company already holds major licenses for the NFL, NBA, and MLB, but its aggressive market consolidation has attracted antitrust lawsuits and accusations of monopolistic behavior. Fanatics expects its collectibles division to generate $5 billion in revenue, while driving innovation through debut patch cards and celebrity partnerships.

Show details
P-SPAC (Unknown)
SpaceX Cancels Thursday's Texas Launch of Starship V3
Reuters | Thu, 21 May 2026 19:51:35 -0400

SpaceX postponed the scheduled Thursday launch of its 12th Starship test flight from Texas, rescheduling the attempt for Friday. This flight represents the debut of a redesigned Starship V3 vehicle, which is central to Elon Musk's lunar and Mars ambitions as well as the company's upcoming U.S. public listing.

Show details
META (Communication Services)

Texas Attorney General Ken Paxton sued WhatsApp and Meta Platforms, alleging they misled consumers about WhatsApp's encryption by falsely claiming messages are secure while allegedly maintaining access to private communications. Meta denied the allegations, stating WhatsApp cannot access encrypted communications. The lawsuit seeks to bar Meta from accessing Texans' WhatsApp messages without consent and demands monetary penalties.

Show details
GOOG (Communication Services) GOOGL (Communication Services)

Waymo has suspended its robotaxi service on freeways across the U.S. and paused operations in Atlanta to update software for better performance around construction zones and flooded roadways. The suspension follows a recall of approximately 3,800 robotaxis earlier this month due to safety concerns about vehicles entering flooded roads at high speeds. The move comes as Waymo accelerates expansion amid growing competition from Tesla and Amazon's Zoox.

Show details
IMAX (Communication Services)
WSJ: IMAX considering sale
Reuters | Thu, 21 May 2026 18:42:33 -0400

Cinema operator IMAX is exploring a potential sale and has approached entertainment companies as possible buyers, according to a Wall Street Journal report. The process is in early stages and may not result in a deal. IMAX declined to comment on the report.

Show details
MTDR (Energy)

Matador Resources acquired 5,154 net undeveloped acres in the core Delaware Basin of southeast New Mexico for approximately $1.1 billion, strengthening its position in the prolific shale play. The acquisition adds over 141 drilling locations with exposure to nine or more drilling zones. The deal will be funded through cash and Matador's existing credit facility.

Show details
BIIB (Healthcare)
Biogen and Denali Halt Parkinson's Drug After Study Failure
Reuters | Thu, 21 May 2026 18:17:14 -0400

Biogen and Denali Therapeutics announced Thursday they are discontinuing development of their Parkinson's disease drug BIIB122 after it failed to meet its primary endpoint in a mid-to-late stage clinical trial. The drug did not slow disease progression compared to placebo in 648 patients with early-stage Parkinson's, despite showing expected biological activity and an acceptable safety profile.

Show details